Brief: Cabaletta Bio Outlines Strategic Priorities And Anticipated Key Milestones For 2025
13/01/2025 14:27
Jan 13 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO OUTLINES STRATEGIC PRIORITIES AND
ANTICIPATED KEY
MILESTONES FOR 2025
* CABALETTA BIO INC - CABALLETTA TO MEET FDA ON RESE-CEL
TRIAL
DESIGNS IN 1H25
Source text: ID:nGNXBmqMx
Further company coverage: CABA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cabaletta Bio
See all newsBrief: Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Cabaletta Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cabaletta Bio Q2 net loss widens as R&D costs rise
Cabaletta Bio, Inc. expected to post a loss of 37 cents a share - Earnings Preview
Cabaletta Bio Inc expected to post a loss of 37 cents a share - Earnings Preview